Clinical Trials in Texas

Showing 9801-9820 of 11,487 trials

Ondansetron and the QT Interval In Adult Emergency Department Patients

NCT01759420

The purpose of this study is to assess the use of the medication ondansetron (zofran) in the emergency department. There are studies of the ability of ondansetron to cause a prolongation in the QT interval (a certain measurement on an EKG) in anesthesia and cancer patients, but not on emergency department patients. This is an observational study where patients that are going to receive the anti-nausea medicine ondansetron in the emergency department will have an EKG performed every 2 minutes for 20 minutes to determine if the QT interval prolongs and returns to normal in that time period. Any serious outcomes will be reported. There is expected to be no adverse outcomes from this routinely used medication.

Ondansetron

C.R.Darnall Army Medical Center28 participantsStarted Dec 2012

Fort Hood, Texas, United States • Tacoma, Washington, United States

COMPLETEDPhase 255 miles

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

NCT01581138

The purpose of this study is to evaluate the efficacy and safety of two all oral regimens in subjects who have chronic hepatitis C and have not received treatment yet.

Chronic Hepatitis C Virus

Vertex Pharmaceuticals Incorporated64 participantsStarted Jul 2012

Birmingham, Alabama, United States • Anaheim, California, United States • Riverside, California, United States +15 more locations

Ondansetron and the QT Interval In Adult Emergency Department Patients

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Find Trials by Condition in Texas

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Dose Range Finding Study of Fedovapagon in Men With Nocturia

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

AST-120 Used to Treat Mild Hepatic Encephalopathy

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery